CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 92 enrolled
Drug / intervention
Restylane Lyft with Lidocainedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02650921
NCT02650921N/ACompleted

A Randomized, Evaluator Blinded, Split-hand Study to Evaluate the Effectiveness and Safety of Restylane Lyft With Lidocaine Compared to no Treatment for Injection in the Dorsal Hand to Correct Volume Deficit

Galderma R&D·interventional·Posted Jan 8, 2016·Updated Aug 26, 2022

In Brief

A clinical study evaluating Restylane Lyft with Lidocaine for Volume Deficit in the Hand. Completed, enrolled 92 participants across 7 sites.

Detailed Summary

This is a randomized, evaluator-blind, split hand, multi-center study of the effectiveness and safety or Restylane Lyft with Lidocaine compared to no treatment for injection in the dorsal hand to correct volume deficits.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJan 8, 2016
Enrollment StartDec 1, 2015
Primary CompletionJul 1, 2016
Study CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 10.5 years ago

Interventions

Restylane Lyft with Lidocainedevice

An injectable gel of Hyaluronic Acid and Lidocaine